Active	Status	Sponsor type	Region	Phase	Filter
1 Active 4 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Biervliet, Stephanie Van
FREE, NCT04646187 / 2020-001811-26: De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease	Enrolling by invitation	4	148	Europe	Infliximab, Remicade, Flixabi, Inflectra, Remsima, Zessly, Adalimumab, Humira, AMGEVITA, Hulio, Hyrimoz, Idacio, Imraldi	University Medical Center Groningen, European Crohn´s and Colitis Organisation, Bühlmann Laboratories AG	Inflammatory Bowel Diseases, Crohn Disease, Colitis, Ulcerative	03/25	03/25